Sage Journals: Discover world-class research

Abstract

According to the doctrine underlying the current radiation protection regulations each, no matter how small, exposure to ionizing radiation may be carcinogenic. However, numerous epidemiological observations demonstrate that cancer incidence and/or mortality are not elevated among inhabitants of the high- versus low-natural-background radiation areas and homes. Results of our own and other authors’ studies described in this paper bear testimony to the possibility that stimulation of the anti-neoplastic immune surveillance mediated by NK lymphocytes and activated macrophages explains, at least partially, the accumulating epidemiological and experimental evidence indicating that low-level exposures to the low-linear energy transfer (LET) radiation inhibit the development of spontaneous and artificial metastases in humans and laboratory animals, respectively. The results presented also suggest the possibility of using low-level X- and gamma-ray exposures to cure cancer and to prevent cancer metastases. For a broader perspective, the results presented may help towards relaxing the current radiation protection regulations, especially as they apply to diagnostic and therapeutic exposures of patients to the indicated forms of radiation.

Keywords

low-level X-rays tumor lung colonies NK cells cytotoxic macrophages anti-neoplastic activity.

I. INTRODUCTION

Humans have always been exposed to various natural sources of ionizing radiation emitted by the isotopes present in the earth's crust, air, water and biosphere, and also originating from the outer space. In some parts of the globe the level of this natural background radiation is significantly higher than the world average with no adverse health effects. Today, people can be additionally exposed to “man-made” radiation delivered at high doses (e.g., during radiotherapy and radiation accidents as well as after detonations of nuclear weapons) or low doses (e.g., during production and distribution of radioactive materials and use of radiation sources for industrial and medical purposes). The low-level environmental and occupational exposures are much more common and distributed over much larger populations than the high-level exposures.

Low doses and dose rates of ionizing radiation (low-level radiation) are defined as those below 0.1–0.2 Gy and below 0.05–0.1 mGy/min., respectively (UNSCEAR 1986, BEIR VII 2006). Absorption of low doses of ionizing radiation may stimulate cellular detoxification and repair mechanisms leading to reduction of the DNA damage even below the spontaneous level and decreasing the probability of neoplastic transformation (for review see: Azzam et al. 1996, Pollycove 2004, 2007, Mitchel 2007, Portess et al. 2007, Redpath and Elmore 2007, Feinendegen et al. 2008). Such exposures may also enhance immune reactions of the organism and attenuate harmful effects of higher doses of radiation (Liu et al. 1982, 1985, Tuschl et al. 1995, Safwat 2000b, Safwat et al. 2003; for review see: Liu 1989, 2004, Luckey 1980, 1999, Ju et al. 1995). These mechanisms may explain various epidemiological observations indicating that cancer incidence and mortality are not elevated among inhabitants of the high-versus low-background radiation areas (Ishii et al. 1996, Kesavan 1997, Jagger 1998; for review see: Luckey 1999, Wei and Sugahara 2000) as well as among tenants of homes with the elevated levels of radiation from ²²²Rn or ⁶⁰Co (Cohen 1995, 1997, UNSCEAR 2000, Wang et al. 2002, Chen et al. 2004). Also, in many cohorts of nuclear workers and in the survivors of the Hiroshima and Nagasaki bombings whose absorbed doses did not exceed 0.25 Gy the incidence of leukemia and some solid tumors has been reported to be lower compared to the respective control groups (Matanoski et al. 1990, Cardis et al. 1995, Pierce et al. 1996, McKinney et al. 1998, Little et al. 1999, UNSCEAR 2000, Berrington et al. 2001, Katayama et al. 2002; for review see: Kondo 1993, Luckey 1999).

These results of epidemiological analyses encouraged many to perform experimental studies utilizing the low-level low-LET irradiations of cells and animals in strictly defined conditions. Such experiments have been providing data which have already contributed to the more detailed understanding of the mechanisms plausibly responsible for the decreased incidence of tumors among people exposed to the low-level ionizing radiation. More broadly, these data may be instrumental in testing the linear-no-threshold (LNT) hypothesis which is central to establishing radiation exposure limits for humans. The LNT hypothesis is based on the controversial assumption that the underlying biological processes triggered by low radiation doses are essentially the same as those that function after higher radiation doses (Mossman 2009, Tubiana 2008). Under the LNT hypothesis, any amount of radiation would be considered to cause cancer among some members of a very large population and cancer risk would increase linearly with increasing dose.

II. ANTI-TUMOR PROPERTIES OF THE LOW-LEVEL LOW-LET IRRADIATIONS

The recent evidence has demonstrated that in animals exposed to single or fractionated low total doses of X- or γ-rays the growth of primary and/or metastatic tumors is inhibited or retarded (Hosoi and Sakamoto 1993, Ishii et al. 1996, Caratero et al. 1998, Cai 1999, Hashimoto et al. 1999, Mitchel et al. 1999, 2003, Wang and Cai 2000, Sakai et al. 2003, Ina and Sakai 2004, for review see: Ju et al. 1995, Liu 2004, 2007). In many of these investigations, anti-tumor properties of the low-level exposures were detected when whole animals were irradiated prior to inoculation of neoplastic cells, indicating that the immune surveillance mechanisms might be involved (Hashimoto et al. 1999, for review see: Safwat 2000a). In their pioneering study, Hosoi and Sakamoto (1993) detected marked reductions in the numbers of both artificial and spontaneous pulmonary metastases after single whole body-irradiation (WBI) of mice with 0.15, 0.2, or 0.5 Gy X-rays. In that study the inhibitory effect was expressed when tumor cells were inoculated either a few hours before or after the exposure. Likewise, Ju et al. (1995) and Cai (1999) who irradiated mice with single doses of X-rays ranging from 0.05 to 0.15 Gy 24 hours before the intravenous (i.v.) injection of B16 melanoma or Lewis Lung Carcinoma (LLC) cells reported a significant retardation of the development of pulmonary tumor nodules. Moreover, a decreased incidence of the lung and lymph node metastases accompanied by the enhanced infiltration of the metastatic foci by lymphocytes was demonstrated by Hashimoto et al. (1999) who exposed rats to 0.2 Gy γ-rays 14 days after subcutaneous (s.c.) implantation of hepatoma cells. Importantly, a local irradiation of the developing tumors did not reduce the number of spontaneous metastases derived thereof. Likewise, Sakai et al. (2003) reported that protracted irradiation of mice with γ-rays at 1 mGy/h dose rate for over 250 days attenuated the growth of the 20-methylocholantrene-induced skin tumors. In our own experiments, two hours after cessation of both single (Fig. 1) and fractionated (Fig. 2) WBI of mice with 0.1 or 0.2 Gy X-rays the animals were i.v. injected with L1 sarcoma cells and 14 days later macroscopic tumor colonies were counted on the lungs’ surfaces (Cheda et al. 2004a, 2004b, 2006, Nowosielska et al. 2005, 2006b, 2008, Janiak et al. 2006). We showed that development of the induced tumor metastases was significantly inhibited after single WBI with the two low doses of X-rays (Fig. 3A and Table 1). Similarly, mice exposed to the total dose of 0.1 or 0.2 Gy applied in ten equal fractions tended to have less pulmonary tumor colonies than sham-exposed control animals (Fig. 3B) (Nowosielska et al. 2008).

TABLE 1.

Relative numbers (percentage of the control value) of the pulmonary L1 sarcoma colonies and cytotoxic activity of the NK cell-enriched splenocytes (NK cells) and IFN-γ- and LPS-stimulated peritoneal macrophages (Mφ) after single WBI (Fig. 1) of mice with 0.1 or 0.2 Gy X-rays and i.p. injection with anti-asialo GM¹ antibody or CGN.

	Pulmonary colonies [% of the control value]			Cytotoxic activity of NK cells [% lysis]		Cytotoxic activity of Mφ [% lysis]
Group	PBS	Ab	CGN	PBS	Ab	PBS	CGN
Control	100	147^∗	401^∗	7.2	0.5^∗	29.4	14.6^∗
0.1 Gy	64^∗	155^∗	352^∗	11.1^∗	0.3^∗	40.4^∗	16.3^∗
0.2 Gy	68^∗	137^∗	387^∗	11.4^∗	0.3^∗	42.1^∗	17.5^∗

The parameters were examined on the 14th (pulmonary colonies), 2nd (NK cells), and 3rd (Mφ) days after single WBI. Control – sham-exposed mice; 0.1 Gy – mice exposed to a single WBI with 0.1 Gy X-rays; 0.2 Gy – mice exposed to a single WBI with 0.2 Gy X-rays; PBS – mice i.p. injected with phosphate buffered saline; Ab – mice i.p. injected with anti-asialo GM¹ antibody; CGN – mice i.p. injected with CGN.

∗

indicates statistically significant (p<0.05) difference from the control/PBS value.

FIGURE 1.

Schematic outline of single exposures of BALB/c mice to X-rays (HS320 Pantak X-ray generator [230 kV, 20 mA] supplied with the Al and Cu filters, at 2.2 Gy/h dose rate) and times of the assessment of tumor lung colonies and activities of the NK cell-enriched splenocytes (NK cells) and peritoneal macrophages (Mφ).

FIGURE 2.

Schematic outline of fractionated exposures of BALB/c mice to X-rays (ANDREX X-ray generator [150 kV, 3 mA], at 2.16 Gy/h dose rate) and times of the assessment of tumor lung colonies and activities of the NK cell-enriched splenocytes (NK cells) and peritoneal macrophages (Mφ).

FIGURE 3.

Relative numbers (percentages of the control values indicated as solid line at 100%) of the induced tumor colonies in the lungs of BALB/c mice exposed to single (A) or fractionated (B) total doses of 0.1 or 0.2 Gy X-rays and two hours later i.v. injected with L1 sarcoma cells. Mean values ± SD (bars) are shown. ∗indicates statistically significant (p<0.05) difference from the control (100%) value.

The above results suggest that the inhibitory effects of the WBI with low doses of X- or γ-rays on the development of both primary and secondary tumor foci may result from stimulation by such exposures of anticancer immune mechanisms rather than from a direct impairment of the viability and/or function of the neoplastic cells.

III. LOW DOSE-INDUCED STIMULATION OF THE ANTI-NEOPLASTIC IMMUNITY

Numerous experimental investigations have demonstrated that exposures to low doses of ionizing radiation spur functions of the anti-neoplastic immune surveillance system. For example, Ina and coworkers (Ina and Sakai 2005a, Ina et al. 2005) showed that chronic irradiation of C57BL/6 mice with γ-rays at 1.2 mGy/h dose rate resulted in the activation of T and B lymphocytes, including the plaque forming cells (PFC), as well as in the total depletion of the abnormal T CD3⁻CD4⁺ lymphocytes. In another study, the same authors demonstrated that chronic low-dose-rate (0.35 or 1.2 mGy/h) irradiation with γ-rays enhanced survival of the MRL-lpr/lpr mice carrying a deletion in the apoptosis-regulating Fas gene leading to a severe autoimmune disease and reduced life-span. This effect was accompanied by significant elevations in the number of CD4⁺CD8⁺ T cells in the thymus and CD8⁺ T cells in the spleen as well as by a marked down-regulation of the abnormal CD3+↑CD45R/B220⁺ and CD45R/B220+↓CD40⁺ splenocytes accompanied by a drastic attenuation of the total-body lymphadenopathy, splenomegaly, proteinuria, and kidney and brain disorders (Ina and Sakai 2004, 2005b).

1. NK cell-mediated activity

Primary cellular effectors of the non-specific anti-tumor surveillance system are natural killer (NK) lymphocytes and activated macrophages (Mφ) (Nathan 1991, Farias-Eisner et al. 1994, Liu et al. 1994a,b, Moretta et al. 1994; for review see: Barao and Ascensao 1998, Al-Sarireh and Eremin 2000). Stimulation of the NK cell-mediated cytotoxicity after a single irradiation of mice was described by Liu et al. (1994b) and by Kojima et al. (2002, 2004). The former group detected the effect 24 hours after exposure to 0.075 Gy X-rays and the latter – between the fourth and sixth hours post irradiation with 0.5 Gy γ-rays. Other authors (Ju et al. 1995) reviewed the enhanced cytocidal function of murine NK-type lymphocytes 2–6 days after a single exposure of the animals to 0.075 Gy X-rays. These findings were corroborated by the results of our own studies demonstrating that single WBI (Fig. 1) of mice with 0.1 or 0.2 Gy X-rays increased the cytolytic function of NK lymphocytes obtained from the spleen (NK cell-enriched splenocytes), as measured by the classic 51Cr release from the YAC-1 tumor target cells; this effect was detectable between the first and third days post-irradiation and was most pronounced on the second day after the exposure (Table 1 and 2) (Cheda et al. 2004a, 2004b, 2006, Nowosielska et al. 2005, 2006a, 2008, Janiak et al. 2006). We also showed that fractionated WBI of mice (Fig. 2) with either of the above two low doses of X-rays led to the significant upregulation of the cytotoxic function of the NK cell-enriched splenocytes (Table 3); in this case the enhanced cytotoxicity was most pronounced between the first and fourth days post-exposure and declined to the baseline level on the seventh day (Nowosielska et al. 2008). When mice were intraperitoneally (i.p.) injected with anti-asialo GM₁ antibody (a classical blocker of the NK cells activity) 24 hours before single WBI, the NK-type activity tested two days later was totally suppressed and this inhibition could not be reversed by a single WBI with 0.1 or 0.2 Gy X-rays (Table 1) (Cheda et al. 2004b, 2006, Nowosielska et al. 2005, Janiak et al. 2006). Moreover, i.p. injection of the anti-asialo GM¹ antibody resulted in the significant increase in the numbers of the tumor colonies developing in the lungs of both irradiated and sham-exposed mice (Table 1).

TABLE 2.

Immunological parameters in mice exposed to single WBI (Fig. 1) with 0.1 or 0.2 Gy X-rays.

Parameter	Control	0.1 Gy	0.2 Gy
Cytotoxicity (NK cells) [% lysis]	7.2	11.1^∗ ↑	11.4^∗ ↑
Expression of FasL by NK cells	3.5	4.9^∗ ↑	4.9^∗ ↑
Cytotoxicity (Mφ) [% lysis]	29.3	40.4^∗ ↑	42.1^∗ ↑
Production of NO by Mφ [μM NO₂–/l]	6.2	21.4^∗ ↑	20.4^∗ ↑
Production of IFN-γ by NK cells [pg/ml]	46	75^∗ ↑	75^∗ ↑
Production of IL-1β by Mφ [pg/ml]	584	1005^∗ ↑	1168^∗ ↑
Production of IL-2 by splenocytes [pg/ml]	19	31^∗ ↑	35^∗ ↑
Production of IL-12 by Mφ [pg/ml]	400	1881^∗ ↑	1844^∗ ↑
Production of TNF-α by Mφ [pg/ml]	6600	8320^∗ ↑	9570^∗ ↑

The parameters were examined on the 2nd (NK cell-enriched splenocytes – NK-cells) and 3rd (PHA-stimulated splenocytes and IFN-γ and LPS-stimulated peritoneal macrophages – Mφ) days after single WBI. Control – sham-exposed mice; 0.1 Gy – mice exposed to a single WBI with 0.1 Gy X-rays; 0.2 Gy – mice exposed to a single WBI with 0.2 Gy X-rays.

∗

indicates statistically significant (p<0.05) difference from the results obtained in the control group.

TABLE 3.

Immunological parameters in mice exposed to fractionated WBI (10 fractions in total: 0.01 or 0.02 Gy per fraction per day for 5 days per week for 2 weeks; Fig. 2) with total doses of 0.1 or 0.2 Gy X-rays.

Parameter	Control	0.1 Gy	0.2 Gy
Cytotoxicity (NK cells) [% lysis]	7.0	11.9^∗ ↑	12.3^∗ ↑
Cytotoxicity (Mφ) [% lysis]	24.7	42.6^∗ ↑	42.9^∗ ↑
Production of NO by Mφ [μM NO₂−/l]	10.7	30.7^∗ ↑	36.8^∗ ↑
Production of IFN-γ by NK cells [pg/ml]	43	87^∗ ↑	89^∗ ↑
Production of IL-1β by Mφ [pg/ml]	532	768^∗ ↑	897^∗ ↑
Production of IL-2 by splenocytes [pg/ml]	19	30^∗ ↑	41^∗ ↑
Production of IL-12 by Mφ [pg/ml]	399	2342^∗ ↑	2898^∗ ↑
Production of TNF-α by Mφ [pg/ml]	6875	33783^∗ ↑	44810^∗ ↑

The parameters were examined on the 3rd (PHA-stimulated splenocytes), 4th (NK cell-enriched splenocytes – NK cells) and 5th (IFN-γ- and LPS-stimulated peritoneal macrophages – Mφ) days after fractionated WBI. Control – sham-exposed mice; 0.1 Gy – mice exposed to total dose of 0.1 Gy X-rays; 0.2 Gy – mice exposed to total dose of 0.2 Gy X-rays.

∗

indicates statistically significant (p<0.05) difference from the results obtained in the control group.

Cytotoxic activity of NK lymphocytes is mediated by the extra-cellularly secreted perforin which creates ‘pores’ in the target cell's membrane whereby the concomitantly released granzymes enter and kill the target (Lord et al. 2003, Smyth et al. 2005). Another potential cytotoxic mechanism consists in the activation of the Fas receptor on the surface of tumor cells upon binding of the specific ligand (FasL) whose expression is upregulated on the activated NK lymphocytes (Reyburn et al. 1997, for review see: Barao and Ascensao 1998). In our experiments suppression of the perforin activity by concanamicin A (CMA) significantly inhibited cytotoxic function of the NK cell-enriched splenocytes collected from both irradiated and non-irradiated mice; the suppression was lower but still significantly expressed when the anti-FasL antibody was added to the incubation medium (Table 4) (unpublished data). Also, surface expression of FasL was significantly increased on the NK-type splenocytes obtained from mice two days after a single WBI (Fig. 1) with 0.1 and 0.2 Gy X-rays, i.e. at the time when the cytotoxic function of these cells was maximally stimulated (Table 2) (Nowosielska et al. 2005, 2006a, Janiak et al. 2006). These results clearly indicate that both secretion of perforin by and expression of FasL on the surface of the effector cells were responsible for the demonstrated by us enhanced cytotoxic function of the NK cell-enriched splenocytes obtained from mice exposed to single irradiations with low doses of X-rays.

TABLE 4.

Inhibition of the cytotoxic activity [expressed in % lysis] of the NK cell-enriched splenocytes (NK cells – inhibited by CMA and anti-FasL Ab) and the IFN-γ- and LPS-stimulated peritoneal macrophages (Mφ – inhibited by CGN and AG) on the 2nd and 3rd days after single WBI (Fig. 1) with X-rays, respectively.

	Cytotoxic activity of NK cells [% lysis]				Cytotoxic activity of Mφ [% lysis]
Groups	CM	CMA	anti-FasL Ab	CMA + anti-FasL Ab	PBS	CGN	AG	CGN + AG
Control	7.2	2.4^∗	4.5^∗	0.6^∗	29.4	14.6 ^a	4.2 ^a	3.8 ^a
0.1 Gy	11.1⁁	3.5^∗ ⁁	6.8^∗ ⁁	0.4^∗	40.4 ^b	16.3 ^a	8.3 ^{a b}	7.9 ^{a b}
0.2 Gy	11.4⁁	3.5^∗ ⁁	7.2^∗ ⁁	1.1^∗ ⁁	42.1 ^b	17.5 ^a	9.5 ^{a b}	8.7 ^{a b}

Control – sham-exposed mice; 0.1 Gy – mice exposed to a single WBI with 0.1 Gy X-rays; 0.2 Gy – mice exposed to a single WBI with 0.2 Gy X-rays.

CM – NK cells incubated in culture medium without blockers; CMA – NK cells incubated with CMA; anti-FasL Ab – NK cells incubated with anti-FasL antibody; CMA + anti-FasL Ab – NK cells incubated with CMA and anti-FasL antibody.

⁁

indicates statistically significant p<0.05) difference between NK cells collected from irradiated mice and the respective NK cells obtained from non-irradiated mice.

∗

indicates statistically significant (p<0.05) difference within each sham-irradiated or irradiated group between NK cells incubated with CMA and/or anti-FasL antibody and NK cells incubated without blockers (CM group).

PBS – Mφ obtained from mice pretreated with PBS; CGN – Mφ obtained from mice pretreated with CGN; AG – Mφ obtained from mice pretreated with PBS and incubated in vitro in the presence of AG; CGN + AG – Mφ obtained from mice pretreated with CGN and incubated in vitro in the presence of AG.

indicates statistically significant (p<0.05) difference within sham-irradiated or irradiated groups between Mφ incubated with AG and/or obtained from mice pretreated with CGN and Mφ collected from mice pretreated with PBS and incubated without AG.

indicates statistically significant (p<0.05) difference between Mφ collected from irradiated mice and the respective Mφ obtained from non-irradiated mice.

2. Macrophage-mediated activity

Activated macrophages (Mφ) kill susceptible tumor cells by means of a number of cytotoxic factors of which nitric oxide (NO) plays a prominent role (Nathan 1991, Cui et al. 1994, Farias-Eisner et al. 1994, Jenkins et al. 1995, Xie and Fidler 1998). Ibuki and Goto (1995) were among the first to demonstrate that irradiation of mice with 0.04 Gy γ-rays stimulated production of NO by the IFN-γ- and LPS-treated peritoneal Mφ collected on the day of exposure. This effect was associated with the significant enhancement of the cytotoxic function of Mφ against the P815 tumor cells. Up-regulated secretion of NO was also described by Pandey et al. (2005) who five times in a row irradiated C57BL/6 mice with 0.04 Gy γ-rays (with the 24-hour intervals between the irradiations) and assessed production of this cytocidal factor by the ConA-stimulated adherent splenocytes on the third day after cessation of the exposures; this effect was associated with the increased phagocytic function of peritoneal exudate cells obtained from the irradiated animals.

The above results were corroborated and extended by us in experiments demonstrating that single exposures (Fig. 1) of mice to 0.1 or 0.2 Gy X-rays led to the significant up-regulation of the cytolytic activity (measured in the ³H-thymidine release assay) of the untreated and IFN-γ and LPS-stimulated peritoneal Mφ against both the L1 (Table 1 and 2) and P815 tumor cells; the effect was most pronounced on the third day and sustained until the ninth day post-irradiation (Cheda et al. 2005, 2006, Janiak et al. 2006, Nowosielska et al. 2006a, 2006b, 2008). Moreover, fractionated WBI of mice (Fig. 2) with either of the two low total doses of X-rays resulted in the significant enhancement of the cytotoxic function of peritoneal Mφ (Table 3) against the L1 cells; the effect was most pronounced between the second and fifth days post-irradiation and declined thereafter (Nowosielska et al. 2008). The up-regulated cytotoxicity was accompanied by the elevated production of NO (Table 2 and 3) (Cheda et al. 2004a, 2005, 2006, Janiak et al. 2006, Nowosielska et al. 2006a, 2006b, 2008) and reactive superoxide anions in the IFN-γ and LPS-treated (NO) or untreated (superoxide anions) peritoneal Mφ (Cheda et al. 2005, Janiak et al. 2006). Interestingly, in these experiments the kinetics of the NO production closely followed the changes in the cytolytic activity of the peritoneal Mφ.

Notably, i.p. injection of mice with carrageenan (CGN – a lysosome-disrupting and phagocyte-damaging compound) (Frank et al. 2003) 24 hours before single WBI resulted in the almost total abrogation of the synthesis of NO in the collected peritoneal Mφ regardless of whether the cells were obtained from the irradiated or sham-exposed mice (Cheda et al. 2006, Janiak et al. 2006, Nowosielska et al. 2006b, 2008). This finding supports a possible involvement of NO in the Mφ-mediated anti-tumor effect of the low-level exposures to X-rays. However, peritoneal Mφ collected from the CGN-treated animals still exhibited cytotoxic activity in vitro, even in the absence of IFN-γ and LPS in the incubation medium. This observation can be explained by triggering of the synthesis of NO in the effector peritoneal Mφ by the target cells (Nowosielska et al. 2006b) and/or involvement of other stimulatory mechanisms in the Mφ-mediated function. Indeed, suppression of the activity of the inducible nitric oxide synthase (iNOS) by aminoguanidine (AG – a classical inhibitor of iNOS) markedly reduced the cytolytic function of the effector peritoneal Mφ obtained from both the sham-exposed and irradiated mice (Table 4) (Nowosielska et al. 2006b).

We also demonstrated that injection of mice with CGN, in addition to the submaximal abrogation of the synthesis of NO in the collected Mφ, totally abolished the inhibitory effect of the irradiations with both 0.1 and 0.2 Gy X-rays on the growth of the induced tumor metastases: the number of the pulmonary colonies developing in the irradiated mice pretreated with CGN did not differ from that obtained in the control animals (Table 1). Interestingly, CGN appeared to be a more potent suppressor of the anti-neoplastic effect of the low-level exposure to X-rays than the anti-asialo GM¹ antibody (Cheda et al. 2004b, 2006, Nowosielska et al. 2005, 2008, Janiak et al. 2006): the suppressive effect of the former was several-fold greater than that of the latter. This observation may be explained by a possible shut-down or reduction by CGN of the cytotoxic functions of Mφ and, indirectly, NK cells. In fact, it has been shown that several cytokines produced by Mφ, such as IL-12 and IL-18, are potent modulators of the activity of NK lymphocytes (for review see Young and Ortaldo 2006) and inhibition of the function of the former cells may affect that of the latter cells in vivo (Fig. 4).

FIGURE 4.

Schematic outline of the possible interactions between NK cells, macrophages, and tumor cells.

3. Cytokines produced by NK cells and macrophages

Notably, the results obtained in our studies indicated that neither the i.p. injection of mice with CGN nor addition of AG to the culture medium led to the complete abrogation of the cytotoxic activity of peritoneal Mφ even when the two blockers were used simultaneously. Likewise, both CMA and the anti-FasL antibody were unable to totally suppress the cytolytic function of the NK cell-enriched splenocytes (Table 4). These findings suggest that the residual cytotoxic activity of the two types of the effector cells may result from the production and secretion of additional cytotoxic and/or cytostatic factors likely to be involved in elimination of neoplastic cells. In fact, both NK lymphocytes and activated Mφ produce a number of cytokines which mediate anti-neoplastic functions of these cells, i.e. either directly suppress proliferation of and/or kill tumor targets (e.g., IL-1β, IFN-γ, TNF-α) or paracrinely stimulate neighboring cells to secrete cytocidal factors (e.g., IL-1β, IL-12, IFN-γ). In fact, researchers in Japan and China, after exposure of mice and rats to single WBI with X- or γ-rays at doses ranging from 0.04 to 0.25 Gy, detected up-regulated secretion and/or expression of mRNAs for IL-1β, IL-12, TNF-α (by Mφ), IFN-γ (by NK cells), and IL-2 (by splenocytes) (DeBlaker-Hohe et al. 1995, Miller et al. 2003, Liu et al. 1994b, 2001, Fu et al. 1996, 1997, Zhang et al. 1996, Gong et al. 1997, Zhang et al. 1998a,b, 1999, Bai et al. 1998, Ibuki and Goto 1999, Hashimoto et al. 1999, Shan et al. 2007, for review see: Al-Sarireh and Eremin 2000, Belardelli and Ferrantini 2002, Liu 2007). In contrast to single irradiations, almost no evidence exists in the literature on triggering of the expression of cytokines by multiple low-level exposures to ionizing radiation. Indeed, Pandey et al. (2005) were unable to detect any stimulation of the production of IFN-γ in splenocytes collected and assayed on the third day after completion of the fractionated (0.04 Gy per day for 5 days) irradiation of the C57BL/6 mice with γ-rays.

These observations were generally corroborated by the results of our own investigations in which peritoneal Mφ and NK cell-enriched splenocytes (Table 2 and 3) were assayed for their capacity to produce the selected cytokines using experimental procedures identical to the ones previously utilized by us for testing of the cytotoxic activity of these cells. Thus, tumor target cells (P815 or L1 for peritoneal Mφ and YAC-1 for NK cell-enriched splenocytes) or PHA (for splenocytes) were included in the incubation wells and then the cell-free supernatants were assayed by the ELISA methodology for the levels of IL-1β, TNF-α, IL-12 (synthesized by peritoneal Mφ), IL-2 (produced by splenocytes), and IFN-γ (secreted by NK cell-enriched splenocytes) (Cheda et al. 2008). In this study, we demonstrated that both single (Fig. 1) and fractionated (Fig. 2) irradiations of mice with total absorbed doses of 0.1 or 0.2 Gy X-rays significantly stimulated peritoneal Mφ to produce IL-1β (Table 2 and 3) (Cheda et al. 2008). Notably, the kinetics of the low-level X-ray-induced production of IL-1β was similar to that detected for the cytotoxic activity and production of NO by peritoneal Mφ obtained after single (Cheda et al. 2005, 2006, Janiak et al. 2006, Nowosielska et al. 2006a,b) or fractionated (Nowosielska et al. 2008) irradiations of mice with 0.1 or 0.2 Gy X-rays. Stimulation of the synthesis of IL-1β was accompanied by the enhanced production of TNF-α after both single (Fig. 1) and fractionated (Fig. 2) irradiations of mice, although the stimulatory effect of the latter exposures on the secretion of TNF-α was much stronger than that detected after the former exposures (Table 2 and 3) (Cheda et al. 2005, 2008, Janiak et al. 2006, Nowosielska et al. 2006a). The radiation-induced upregulated production of IL-1β and TNF-α coincided with the elevated secretion of IL-12 (Table 2 and 3) (Cheda et al. 2008). Moreover, both single (Fig. 1) and fractionated (Fig. 2) WBI of mice with 0.1 or 0.2 Gy X-rays significantly stimulated synthesis of IL-2 and IFN-γ in the unseparated and the NK cell-enriched splenocytes, respectively (Table 2 and 3) (Cheda et al. 2008). Importantly, the time course of the changes in the production of IFN-γ after a single but not fractionated irradiation of mice with either of the two low doses of X-rays closely resembled the kinetics of the previously demonstrated by us (Cheda et al. 2004a,b, 2006, Nowosielska et al. 2005, 2006a, 2008, Janiak et al. 2006) enhanced cytotoxicity of the NK cell-enriched splenocytes obtained from the similarly exposed animals.

4. NK cell- and macrophage-mediated activities after in vitro irradiation

In contrast to the single and fractionated WBI of mice with low doses of X-rays, we showed that the in vitro irradiations of NK cell-enriched splenocytes and peritoneal Mφ did not significantly affect the NK cell- and Mφ-mediated functions (Table 5). This observations suggests that the above described anti-tumor properties of both single and fractionated irradiations with low total doses of X-rays result from the stimulated interaction of many components of the complex immune surveillance system rather than from boosting of function(s) of a single cell population.

TABLE 5.

Effects of the in vitro irradiation of NK cell-enriched splenocytes (NK cells) and the IFN-γ- and LPS-stimulated peritoneal macrophages (Mφ) with low doses of X-rays.

	NK cells		Mφ
Groups	Cytotoxicity [% lysis]	Production of IFN-γ [pg/ml]	Cytotoxicity [% lysis]	Production of NO [μM NO₂–/l]
Control	6.0	46.1	25.2	12.5
0.1 Gy	5.5	51.3	24.6	11.8
0.2 Gy	5.8	53.7	24.9	13.1

Control – sham-exposed NK cells or Mφ; 0.1 Gy – NK cells or Mφ exposed to single irradiation with 0.1 Gy X-rays; 0.2 Gy – NK cells or Mφ exposed to single irradiation with 0.2 Gy X-rays.

IV. IMPLICATIONS

Results of the epidemiological and experimental studies presented in this paper indicate that low-level exposures to X- and γ-rays may suppress the development and progression of tumors and that these effects can be associated with stimulation by such irradiations of anti-neoplastic functions of the immune system. This type of the radiation-evoked hormetic effect (for review see: Luckey 1980, Webster 1993, Calabrese and Baldwin 2002, Pollycove 2007, Feinendegen et al. 2008) may have several implications.

Firstly, the described experimental data provide clues for, at least partial, explanation of the inhibitory effects of the low-level exposures to the low-LET radiation on the development and progression of tumors. Indeed, these low-dose data contradict the commonly applied LNT model-related assumption that the underlying biological processes that function after low radiation doses are essentially the same as those that function after higher radiation doses (for review see: Averbeck et al. 2006, Tubiana and Aurengo 2006, Tubiana et al. 2006a,b, Tubiana 2008, 2009).

Secondly, after careful preclinical and clinical trials, low-level exposures to X- or γ-rays could be employed as a new modality in the treatment of cancer. Indeed, the half or total body exposures to low doses of X-rays have been already tested in experimental therapeutic protocols as complements to the standard chemo- and/or radiotherapy of ovarian and colon cancer, as well as non-Hodgkin lymphoma (Choi et al. 1979, Sakamoto et al. 1997, for review see Cuttler and Pollycove 2003). As indicated recently by Tubiana in his review of the current data (Tubiana 2009), the risk of the second primary malignancies associated with therapeutical application of the total doses of radiation lower than 0.1–0.2 Gy is negligible.

Thirdly, the results of the investigations described above as well as other supporting radiation-adaptive-response data may in a broader perspective contribute to relaxing the current stringent radiation protection regulations. This includes regulations that govern diagnostic and therapeutic applications of ionizing radiation as well as those related to occupational and environmental radiation exposures. Current regulations are based on the controversial LNT hypothesis (ICRP 1990, 2006; Mossman 2009) which imposes avoiding exposures to even very low doses and dose rates of radiation. This practice not only elevates the costs of the enforcement of the protective measures, but may also have – opposite to the intentions – adverse health effects (for review see Jaworowski 2000, 2009).

References

Al-Sarireh

and Eremin

2000. Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb 45:1–16

Averbeck

Testard

, and Boucher

2006. Changing views on ionising radiation-induced cellular effects. Int J Low Radiation 3:117–134

Azzam

de Toledo

Raaphorst

, and Mitchel

RE.

1996. Low-dose ionizing radiation decreases the frequency of neoplastic transformation to a level below the spontaneous rate in C3H 10T1/2 cells. Radiat Res 146:369–373

Bai

Liu

, and Mu

1998. Effect of low dose radiation on Th1 and Th2 of thymocytes and splenocytes in mice. Chin J Radiol Med Prot 18:106–109

Barao

and Ascensao

JL.

1998. Human natural killer cells. Arch Immunol Ther Exp 46:213–229

Belardelli

and Ferrantini

2002. Cytokines as a link between innate and adaptive antitumour immunity. Trends Immunol 23:201–208

Berrington

Darby

Weiss

, and Doll

2001. 100 years of observation on British radiologists: mortality from cancer and other causes 1897–1997. Br J Radiol 74:507–519

Cai

1999. Research of the adaptive response induced by low-dose radiation: Where have we been and where should we go? Hum Exp Toxicol 18:419–425

Calabrese

and Baldwin

LA.

2002. Radiation hormesis and cancer. Hum Ecol Risk Assess 8:327–353

10.

Caratero

Courtade

Bonnet

Planel

, and Caratero

1998. Effect of a continuous gamma irradiation at a very low dose on the life span of mice. Gerontology 44: 272–276

11.

Cardis

Gilbert

Carpenter

Howe

Kato

Armstrong

Beral

Cowper

, and Douglas

1995. Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 142:117–32

12.

Cheda

Nowosielska

Wrembel-Wargocka

, and Janiak

MK.

2008. Production of cytokines by peritoneal macrophages and splenocytes after exposures of mice to low doses of X-rays. Radiat Environ Biophys 47:275–283

13.

Cheda

Wrembel-Wargocka

Lisiak

Marciniak

Nowosielska

, and Janiak

MK.

2004a. Inhibition of the development of pulmonary tumour nodules and stimulation of the activity of NK cells and macrophages in mice by single low doses of low-LET radiation. Int J Low Radiation 1:171–179

14.

Cheda

Wrembel-Wargocka

Lisiak

Nowosielska

Marciniak

, and Janiak

MK.

2004b. Single Low Doses of X-Rays Inhibit the Development of Experimental Tumor Metastases and Trigger the Activities of NK Cells in Mice. Radiat Res 161:335–340

15.

Cheda

Wrembel-Wargocka

Nowosielska

, and Janiak

MK.

2005. Stimulatory effect of a single low-level irradiation with X-rays on functions of murine peritoneal macrophages. Nukleonika 50(Suppl. 2):S13–S16

16.

Cheda

Wrembel-Wargocka

Nowosielska

, and Janiak

MK.

2006. Immune mechanism of the retarded growth of tumor nodules in mice exposed to single low-level irradiations with X-rays. Centr Eur J Immunol 31:44–50

17.

Chen

Luan

Shieh

Chen

Kung

Soong

Yeh

Chou

Mong

Sun

Deng

, and Shen

ML.

2004. Is chronic radiation an effective prophylaxis against cancer? J Am Physicians Surg 9:6–10

18.

Choi

Timothy

Kaufman

Carey

, and Aisenberg

AC.

1979. Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin's lymphoma. Cancer 43:1636–1642

19.

Cohen

BL.

1995. Test the linear-no threshold theory of radiation carcinogenesis for inhaled radon decay products. Health Phys 86:157–174

20.

Cohen

BL.

1997. Problems in the radon vs lung cancer test of linear no-threshold theory and a procedure for resolving them. Health Phys 72:623–628

21.

Cui

Reichner

Mateo

, and Albina

JE.

1994. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res 54:2462–2467

22.

Cuttler

and Pollycove

2003. Can cancer be treated with low doses of radiation? J Am Phys Surg 8:108–111

23.

DeBlaker-Hohe

Yamauchi

Horvath-Arcidiacono

, and Bloom

ET.

1995. IL-12 synergises with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell Immunol 165:33–43

24.

Farias-Eisner

Sherman

Aeberhard

, and Chaudhuri

1994. Nitric oxide is an important mediator for tumoricidal activity in vivo . Proc Natl Acad Sci USA 91:9407–9411

25.

Feinendegen

Hahnfeldt

Schadt

Stumpf

, and Voit

EO.

2008. Systems biology and its potential role in radiobiology. Radiat Environ Biophys 47:5–23

26.

Frank

Born

Barker

, and Marzi

2003. In vivo effect of tumor necrosis factor alpha on wound angiogenesis and epithelialization. Eur J Trauma 29:208–219

27.

Chen

Zhang

, and Liu

SZ.

1997. Mechanism of suppressive effect of low dose radiation on cancer cell dissemination in mice. J Radiat Res Radiat Process 15:40–43

28.

, and Liu

SZ.

1996. Whole-body low dose irradiation suppresses cancer cell dissemination in mice. Chin J Radiol Med Prot 16:307–309

29.

Gong

Liu

Zhang

, and Liu

SZ.

1997. Effect of splenocyte extracellular fluid irradiated with low dose X-rays on thymocyte apoptosis after larger dose X-irradiation in mice. J Radiat Res Radiat Process 15:36–39

30.

Hashimoto

Shirato

Hosokawa

Nishioka

Kuramitsu

Matushita

Kobayashi

, and Miyasaka

1999. The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats. Radiat Res 151: 717–724

31.

Hosoi

and Sakamoto

1993. Suppressive effect of low dose total body irradiation on lung metastasis: dose dependency and effective period. Radiother Oncol 26:177–179

32.

Ibuki

and Goto

1999. Contribution of inflammatory cytokine release to activation of resident peritoneal macrophages after in vivo low-dose γ-irradiation. J Radiat Res 40:253–262

33.

Ibuki

and Goto

1995. Augmentation of NO production and cytolytic activity of Mφ obtained from mice irradiated with a low dose of γ-rays. J Radiat Res 36:209–220

34.

ICRP (International Commission on Radiological Protection). 1990. Recommendations of the International Commission on Radiological Protection, Publication 60. Elsevier, London

35.

ICRP (International Commission on Radiological Protection). 2006. Low-dose Extrapolation of Radiation Related Cancer Risk. Publication 99. Elsevier, London

36.

Ina

and Sakai

2004. Prolongation of life span associated with immunological modification by chronic low-dose-rate irradiation in MRL-lpr/lpr mice. Radiat Res 16:168–173

37.

Ina

and Sakai

2005a. Activation of immunological network by chronic low-dose-rate irradiation in wild-type mouse strains; Analysis of immune cell populations surface molecules. Int J Radiat Biol 81:721–729

38.

Ina

and Sakai

2005b. Further study on prolongation of life span associated with immunological modification by chronic low-dose-rate irradiation in MRL-lpr/lpr mice: effects of whole-life irradiation. Radiat Res 163:418–423

39.

Ina

Tanooka

Yamada

, and Sakai

2005. Suppression of thymic lymphoma induction by lifelong low-dose-rate irradiation accompanied by immune activation in C57BL/6 mice. Radiat Res 163:153–158

40.

Ishii

Hosoi

Yamada

Ono

, and Sakamoto

1996. Decreased incidence of thymic lymphoma in AKR mice as a result of chronic, fractionated low-dose total-body X irradiation. Radiat Res 146:582–585

41.

Jagger

1998. Natural background radiation and cancer death in Rocky Mountain states and Gulf Coast states. Health Phys 7:428–430

42.

Janiak

Wrembel-Wargocka

Cheda

Nowosielska

Lisiak

, and Bilski

2006. Modulation of the antitumour functions of murine NK cells and macrophages after single low-level exposures to X-rays. Int J Low Radiation 3:178–191

43.

Jaworowski

2000. Beneficial radiation and regulations. Proc. of 8th International Conference on Nuclear Engineering (ICONE 8), Baltimore, USA, Paper No. 8790. American Society of Mechanical Engineers, New York

44.

Jaworowski

2009. Radiation hormesis – a remedy for fear. BELLE News 15:14–20

45.

Jenkins

Charles

Thomsen

Moss

Holmes

Baylis

Rhodes

Westmore

Emson

, and Moncada

1995. Role of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92:4392–4396

46.

Liu

, and Fu

HQ.

1995. Effect of high versus low dose radiation on the immune system. In: Hagen

Harder

Jung

Streffer

(eds) Radiation Research 1895–1995. Proc of the Tenth Int Congress of Radiation Research, pp 709–714. Würzburg, Germany

47.

Katayama

Matsuura

Endo

Hosoi

Othaki

, and Hayakawa

2002. Reassessment of the cancer mortality risk among Hiroshima atomic-bomb survivors using a new dosimetry system, ABS2000D, compared with ABS93D. J Radiat Res 43: 53–64

48.

Kesavan

PC.

1997. Indian research on high levels of natural radiation: pertinent observations for further studies. In: Wei

Sugahara

Tao

(eds) High levels of natural radiation, 1996: Radiation dose and health effects. Proc. of 4th International Conference on High Levels of Natural Radiation, Beijing, China. pp. 112–117. Elsevier, Amsterdam, Netherlands

49.

Kojima

Ishida

Takahashi

, and Yamaoka

2002. Elevation of glutathione induced by low-dose gamma rays and its involvement in increased natural killer activity. Radiat Res 157:275–280

50.

Kojima

Nakayama

, and Ishida

2004. Low dose γ-rays activate immune functions via induction of glutathione and delay tumor growth. J Radiat Res 45:33–39

51.

Kondo

1993. Health effects of low level radiation. Kinki University Press, Osaka, Japan

52.

Little

Weiss

, and Boice

JD.

1999. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. Radiat Res 152:280–292

53.

Liu

Han

, and Liu

WH.

1994a. Changes in lymphocyte reactivity to modulatory factors following low dose ionizing radiation. Biomed Environ Sci 7:130–135

54.

Liu

Jin

Liu

, and Sun

YM.

2001. Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes. BMC Immunol 2:8–15

55.

Liu

Zhang

, and Zhao

1994b. Signal transduction in lymphocytes after low dose radiation. Chin Med J 107:431–436

56.

Liu

Xiao

Tian

, and Zhang

LM.

1982. A study of the immune status of inhabitants in an area of high natural radioactivity in Guangdong. Chin J Radiol Med Prot 2:64–68

57.

Liu

Xia

Wang

, and Wang

SK.

1985. A restudy of immune functions of the inhabitants in a high natural radioactivity area in Guangdong. Chin J Radiol Med Prot 5:124–127

58.

Liu

SZ.

1989. Radiation hormesis. A new concept in radiological science. Chin Med J 102:750–755

59.

Liu

SZ.

2004. Cancer control related to stimulation of immunity by low dose radiation. In: Proc. of 14th Pacific Basin Nuclear Conference, Honolulu, USA. pp 368–372. American Nuclear Society, La Grange Park, Illinois

60.

Liu

SZ.

2007. Cancer Control Related to Stimulation of Immunity by Low-Dose Radiation. Dose Response 5:39–47

61.

Lord

Rajotte

Korbutt

, and Blezckley

RC.

2003. Granzyme B: a natural born killer. Immunol Rev 193:31–38

62.

Luckey

TD.

1980. Hormesis of Ionizing Radiation. CRC Press, Boca Raton, Florida, USA

63.

Luckey

TD.

1999. Nurture with ionising radiation: a provocative hypothesis. Nutr Cancer 34: 1–11

64.

Matanoski

Santos-Burgoa

, and Schwartz

1990. Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943–1982). Environ Health Perspect 86:107–117

65.

McKinney

Aquilla

Coffin

Wink

, and Vodovotz

1998. Origin and functions of human natural killer cells. J Leukocyte Biol 64:459–466

66.

Miller

Kim

Andres

Green

, and Gridley

DS.

2003. Changes in the activation and reconstitution of lymphocytes resulting from total-body irradiation correlate with slowed tumor growth. Oncology 65:229–241

67.

Mitchel

Jackson

McCann

, and Boreham

DR.

1999. The adaptive response modifies latency for radiation-induced myeloid leukemia in CBAH mice. Radiat Res 152:273–279

68.

Mitchel

Jackson

Morrison

, and Carlisle

SM.

2003. Low doses of radiation increase the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat Res 159:320–327

69.

Mitchel

REJ.

2007. Low doses of radiation reduce risk in vivo . Dose-Response 5:1–10

70.

Moretta

Ciccone

Poggi

Mingari

, and Moretta

1994. Origin and functions of human natural killer cells. Int J Clin Lab Res 24:181–186

71.

Mossman

KS.

2009. Policy decision-making under scientific uncertainty: Radiological risk assessment and the role of expert advisory groups. Health Phys 97:101–106

72.

Nathan

1991. Mechanisms and modulation of macrophage activation. Behrings Inst Mitt 88:200–207

73.

National Research Council (NRC Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation). 2006. Health Risks from Exposure to Low Levels of Ionizing Radiation (BEIR VII, Phase 2). National Academy Press, Washington, DC

74.

Nowosielska

Cheda

Wrembel-Wargocka

, and Janiak

MK.

2008. Modulation of the growth of pulmonary tumour colonies in mice after single or fractionated low-level irradiations with X-rays. Nukleonika 53(Suppl. 1):S9–S15

75.

Nowosielska

Wrembel-Wargocka

Cheda

, and Janiak

MK.

2006a. A single low-dose irradiation with X-rays stimulates NK cells and macrophages to release factors related to the cytotoxic functions of these cells. Centr Eur J Immunol 31:51–57

76.

Nowosielska

Wrembel-Wargocka

Cheda

Lisiak

, and Janiak

MK.

2005. Low-level exposures to ionising radiation modulate the anti-tumour activity of murine NK cells. Nukleonika 50(Suppl. 2):S21–S24

77.

Nowosielska

Wrembel-Wargocka

Cheda

Lisiak

, and Janiak

MK.

2006b. Enhanced cytotoxic activity of macrophages and suppressed tumor metastases in mice irradiated with low doses of X-rays. J Radiat Res 47:229–236

78.

Pandey

Shankar

Sharma

, and Sainis

KB.

2005. Low dose radiation induced immunomodulation: effect on macrophages and CD8⁺ T cells. Int J Radiat Biol 81:801–812.

79.

Pierce

Shimizu

Preston

Vaeth

, and Mabuchi

1996. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950–1990. Radiat Res 146:1–27

80.

Pollycove

2004. Radiobiological basis of low dose irradiation in prevention and therapy of cancer. In: Proc. of 14th Pacific Basin Nuclear Conference, Honolulu, USA. pp 647–653. American Nuclear Society, La Grange Park, Illinois

81.

Pollycove

2007. Radiobiological basis of low-dose irradiation in prevention and therapy of cancer. Dose-Response 5:26–38

82.

Portess

Bauer

Hill

, and O'Neill

2007. Low-dose irradiation of nontransformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis. Cancer Res 67:1246–1253

83.

Redpath

and Elmore

2007. Radiation-induced neoplastic transformation in vitro, hormesis and risk assessment. Dose-Response 5:123–130

84.

Reyburn

Mandelboim

Vales-Gomez

Sheu

Pazmany

Davis

, and Strominger

JL.

1997. Human NK cells: their ligands, receptors and functions. Immunol Rev 155:119–125

85.

Safwat

Bayoumy

El-Sharkawy

Shaaban

Mansour

, and Kamel

2003. The potential palliative role and possible immune modulatory effects of low-dose total body irradiation in relapsed or chemo-resistant non-Hodgkin's lymphoma. Radiother Oncol 69:33–36

86.

Safwat

2000a. The immunology of low-dose total-body irradiation: more questions than answers. Radiat Res 153:599–604

87.

Safwat

2000b. The role of low-dose total body irradiation in treatment of non-Hodgkin's lymphoma: a new look at an old method. Radiother Oncol 56:1–6

88.

Sakai

Hoshi

Nomura

Oda

Iwasaki

Fujita

Yamada

and Tanooka

2003. Suppression of carcinogenic processes in mice by chronic low dose rate gamma-irradiation. Int J Low Radiation 1:142–146

89.

Sakamoto

Myogin

, and Hosoi

1997. Fundamental and clinical studies on cancer control with total or upper half body irradiation. J Jpn Soc Ther Radiol Oncol 16:161–175

90.

Shan

Jin

Liu

, and Liu

SZ.

2007. Ionizing radiation stimulates secretion of proinflammatory cytokines: dose-response relationship, mechanisms and implications. Radiat Environ Biophys 46:21–29

91.

Smyth

Cretney

Kelly

Westwood

Street

Yagita

Takeda

van Dommelen

Degli-Esposti

, and Hayakawa

2005. Activation of NK cell cytotoxicity. Mol Immunol 42:501–510

92.

Tubiana

and Aurengo

2006. Dose–effect relationship and estimation of the carcinogenic effects of low doses of ionising radiation: the Joint Report of the Académie des Sciences (Paris) and of the Académie Nationale de Médecine. Int J Low Radiation 2:135–153

93.

Tubiana

Aurengo

Averbeck

, and Masse

2006a. Recent reports on the effect of low doses of ionizing radiation and its dose–effect relationship. Radiat Environ Biophys 44:245–251

94.

Tubiana

Aurengo

Averbeck

, and Masse

2006b. The debate on the use of linear no threshold for assessing the effects of low doses. J Radiol Prot 26:317–324

95.

Tubiana

2008. The 2007 Marie Curie prize: the linear no threshold relationship and advances in our understanding of carcinogenesis. Int J Low Radiation 5:173–204

96.

Tubiana

2009. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91:4–15

97.

Tuschl

Steger

, and Kovac

1995. Occupational exposure and its effect on some immune parameters. Health Phys 68:59–66

98.

UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). 2000. Epidemiological Evaluation of Radiation-Induced Cancer, In: Sources and Effects of Ionizing Radiation, Annex I. pp 297–450

99.

UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). 1986. Genetic and Somatic Effects of Ionizing Radiation. In: Report to the General Assembly, with Annexes. p 170

100.

Wang

and Cai

2000. Induction of cell-proliferation hormesis and cell-survival adaptive response in mouse hematopoietic cells by whole-body low-dose radiation. Toxicol Sci 53:369–376

101.

Wang

Lubin

Wang

Zhang

Boice

Cui

Zhang

Conrath

Xia

Shang

Brenner

Lei

Metayer

Cao

Chen

Lei

, and Kleinerman

RA.

2002. Residential radon and lung cancer risk in a high-exposure area of Gansu Province, China. Am J Epidemiol 155:554–564

102.

Webster

EW.

1993. Hormesis and radiation protection. Invest Radiol 28:451–453

103.

Wei

and Sugahara

2000. An introductory overview of the epidemiological study on the population at the high background radiation areas in Yangjiang, China. J Radiat Res 41(Suppl):1–7

104.

Xie

and Fidler

IJ.

1998. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Met Rev 17:55–75

105.

Young

and Ortaldo

2006. Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells. Cell Res 16:20–24

106.

Zhang

Chen

, and Liu

SZ.

1996. Effects of low dose irradiation on the splenic macrophage function in mice. J N Bethune Univ Med Sci 22:131–133

107.

Zhang

, and Liu

SZ.

1999. Stimulatory effect of low dose radiation on the immune function in tumor-bearing mice. J N Bethune Univ Med Sci 25:592–594

108.

Zhang

Sun

, and Liu

SZ.

1998a. An experimental study on the enhanced macrophage function in tumor-bearing mice treated with low dose radiation. J Radiat Res Radiat Proces 16:249–252

109.

Zhang

Sun

, and Liu

SZ.

1998b. Low dose radiation increases the mRNA transcriptional levels of IL-1beta and TNF-alpha in peritoneal macrophages of tumor-bearing mice. J N Bethune Univ Med Sci 24:565–567

Immunological Mechanism of the Low-Dose Radiation-Induced Suppression of Cancer Metastases in a Mouse Model

Abstract

Keywords

I. INTRODUCTION

II. ANTI-TUMOR PROPERTIES OF THE LOW-LEVEL LOW-LET IRRADIATIONS

III. LOW DOSE-INDUCED STIMULATION OF THE ANTI-NEOPLASTIC IMMUNITY

1. NK cell-mediated activity

2. Macrophage-mediated activity

3. Cytokines produced by NK cells and macrophages

4. NK cell- and macrophage-mediated activities after in vitro irradiation

IV. IMPLICATIONS

References